Weiskirchen R - Search Results

1

Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1β through nuclear factor-κB activation.

Borkham-Kamphorst E, Drews F, Weiskirchen R. Borkham-Kamphorst E, et al. Among authors: weiskirchen r. Liver Int. 2011 May;31(5):656-65. doi: 10.1111/j.1478-3231.2011.02495.x. Epub 2011 Mar 16. Liver Int. 2011. PMID: 21457438

2

Comparative evaluation of gene delivery devices in primary cultures of rat hepatic stellate cells and rat myofibroblasts.

Weiskirchen R, Kneifel J, Weiskirchen S, van de Leur E, Kunz D, Gressner AM. Weiskirchen R, et al. Among authors: weiskirchen s. BMC Cell Biol. 2000;1:4. doi: 10.1186/1471-2121-1-4. Epub 2000 Dec 19. BMC Cell Biol. 2000. PMID: 11178102 Free PMC article.

3

LIM-domain protein cysteine- and glycine-rich protein 2 (CRP2) is a novel marker of hepatic stellate cells and binding partner of the protein inhibitor of activated STAT1.

Weiskirchen R, Moser M, Weiskirchen S, Erdel M, Dahmen S, Buettner R, Gressner AM. Weiskirchen R, et al. Among authors: weiskirchen s. Biochem J. 2001 Nov 1;359(Pt 3):485-96. doi: 10.1042/0264-6021:3590485. Biochem J. 2001. PMID: 11672422 Free PMC article.

4

Roles of TGF-beta in hepatic fibrosis.

Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Gressner AM, et al. Among authors: weiskirchen r. Front Biosci. 2002 Apr 1;7:d793-807. doi: 10.2741/A812. Front Biosci. 2002. PMID: 11897555 Review.

5

Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.

Arias M, Lahme B, Van de Leur E, Gressner AM, Weiskirchen R. Arias M, et al. Among authors: weiskirchen r. Cell Growth Differ. 2002 Jun;13(6):265-73. Cell Growth Differ. 2002. PMID: 12114216

6

Adenoviral-mediated transfer of p53 or retinoblastoma protein blocks cell proliferation and induces apoptosis in culture-activated hepatic stellate cells.

Abriss B, Hollweg G, Gressner AM, Weiskirchen R. Abriss B, et al. Among authors: weiskirchen r. J Hepatol. 2003 Feb;38(2):169-78. doi: 10.1016/s0168-8278(02)00361-6. J Hepatol. 2003. PMID: 12547405

7

Rapid detection of CSRP2 mRNA in mouse, rat, and human using LightCycler-based quantitative real-time polymerase chain reaction.

Günther K, Stoll D, Jakse G, Gressner AM, Weiskirchen R. Günther K, et al. Among authors: weiskirchen r. Anal Biochem. 2003 Mar 1;314(1):144-8. doi: 10.1016/s0003-2697(02)00627-9. Anal Biochem. 2003. PMID: 12633614 No abstract available.

8

Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats.

Arias M, Sauer-Lehnen S, Treptau J, Janoschek N, Theuerkauf I, Buettner R, Gressner AM, Weiskirchen R. Arias M, et al. Among authors: weiskirchen r. BMC Gastroenterol. 2003 Oct 18;3:29. doi: 10.1186/1471-230X-3-29. BMC Gastroenterol. 2003. PMID: 14565855 Free PMC article.

9

Analysis of the transforming growth factor-beta1 (TGF-beta1) codon 25 gene polymorphism by LightCycler-analysis in patients with chronic hepatitis C infection.

Tag CG, Mengsteab S, Hellerbrand C, Lammert F, Gressner AM, Weiskirchen R. Tag CG, et al. Among authors: weiskirchen r. Cytokine. 2003 Dec 7;24(5):173-81. doi: 10.1016/j.cyto.2003.08.007. Cytokine. 2003. PMID: 14596813

10

Induction of cell death in activated hepatic stellate cells by targeted gene expression of the thymidine kinase/ganciclovir system.

Janoschek N, van de Leur E, Gressner AM, Weiskirchen R. Janoschek N, et al. Among authors: weiskirchen r. Biochem Biophys Res Commun. 2004 Apr 16;316(4):1107-15. doi: 10.1016/j.bbrc.2004.02.147. Biochem Biophys Res Commun. 2004. PMID: 15044099

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results